<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7745554</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33402860</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7745554</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1177/1179573520976832</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">10.1177_1179573520976832</article-id></all-ids><extracted-table><table-id>table1-1179573520976832</table-id><table-label>Table 1.</table-label><table-caption>Summary of the demographic, experimental, and outcome measurement details of the included studies.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="table1-1179573520976832" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Summary of the demographic, experimental, and outcome measurement details of the included studies.</p></caption><alternatives><graphic xlink:href="10.1177_1179573520976832-table1"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Reference</th><th align="left" rowspan="2" colspan="1">Study design</th><th align="left" colspan="4" rowspan="1">Participants characteristics</th><th align="left" colspan="5" rowspan="1">Experimental details</th><th align="left" colspan="2" rowspan="1">Outcome measures</th></tr><tr><th align="left" rowspan="1" colspan="1">Neurological diagnosis</th><th align="left" rowspan="1" colspan="1"><italic>N</italic></th><th align="left" rowspan="1" colspan="1">Age group</th><th align="left" rowspan="1" colspan="1">Concurrent medication</th><th align="left" rowspan="1" colspan="1">Stimulation type</th><th align="left" rowspan="1" colspan="1">Total stimulation time (min)</th><th align="left" rowspan="1" colspan="1">Current density (A/m<sup>2</sup>)</th><th align="left" rowspan="1" colspan="1">Concurrent task</th><th align="left" rowspan="1" colspan="1">Mean washout period (d)</th><th align="left" rowspan="1" colspan="1">Clinical outcome (description)</th><th align="left" rowspan="1" colspan="1">rsFC outcome</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">De Ridder and Vanneste<sup><xref rid="bibr49-1179573520976832" ref-type="bibr">49</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1">Fibromyalgia</td><td rowspan="1" colspan="1">A:19</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Bilateral</td><td rowspan="2" colspan="1">300</td><td rowspan="2" colspan="1">0.429</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Symptomatic relief (pain perception)</td><td rowspan="2" colspan="1">EEG phase lagged index</td></tr><tr><td rowspan="1" colspan="1">S:12</td></tr><tr><td rowspan="2" colspan="1">Neeb et al<sup><xref rid="bibr50-1179573520976832" ref-type="bibr">50</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1">Inflammatory bowel disorder</td><td rowspan="1" colspan="1">A:24</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Anodal</td><td rowspan="2" colspan="1">100</td><td rowspan="2" colspan="1">0.571</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="1" colspan="1"/><td rowspan="2" colspan="1">fMRI whole-brain rsFC</td></tr><tr><td rowspan="1" colspan="1">S:12</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Porcaro et al<sup><xref rid="bibr54-1179573520976832" ref-type="bibr">54</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Multiple sclerosis</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Anodal</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">Varied</td><td rowspan="1" colspan="1">Nil</td><td rowspan="1" colspan="1">Not stated</td><td rowspan="1" colspan="1">Symptomatic relief (fatigue perception)</td><td rowspan="1" colspan="1">EEG mutual information</td></tr><tr><td rowspan="2" colspan="1">Mondino et al<sup><xref rid="bibr51-1179573520976832" ref-type="bibr">51</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">A:11</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Cathodal</td><td rowspan="2" colspan="1">200</td><td rowspan="2" colspan="1">0.571</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Symptomatic relief (auditory hallucination)</td><td rowspan="4" colspan="1">fMRI seed-whole brain rsFC</td></tr><tr><td rowspan="1" colspan="1">S:12</td></tr><tr><td rowspan="2" colspan="1">Palm et al<sup><xref rid="bibr27-1179573520976832" ref-type="bibr">27</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1"/><td rowspan="1" colspan="1">A:10</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Anodal</td><td rowspan="2" colspan="1">200</td><td rowspan="2" colspan="1">0.571</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Symptomatic relief (psychiatric symptoms)</td></tr><tr><td rowspan="1" colspan="1">S:10</td></tr><tr><td rowspan="1" colspan="1">Shahbabaie et al<sup><xref rid="bibr53-1179573520976832" ref-type="bibr">53</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Substance abuse</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Bilateral</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">0.571</td><td rowspan="1" colspan="1">Nil</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">Symptomatic relief (drug craving intention)</td><td rowspan="1" colspan="1">fMRI whole-brain rsFC</td></tr><tr><td rowspan="1" colspan="1">Sotnikova et al<sup><xref rid="bibr57-1179573520976832" ref-type="bibr">57</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">ADHD</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">Adolescent</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Anodal</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">0.769</td><td rowspan="1" colspan="1"><italic>n</italic>-back task</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">Enhancement of specific neurological function (working memory performance)</td><td rowspan="1" colspan="1">fMRI seed-whole brain rsFC</td></tr><tr><td rowspan="2" colspan="1">Cosmo et al<sup><xref rid="bibr58-1179573520976832" ref-type="bibr">58</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1"/><td rowspan="1" colspan="1">A:30</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Not stated</td><td rowspan="2" colspan="1">Bilateral</td><td rowspan="2" colspan="1">20</td><td rowspan="2" colspan="1">0.286</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">N/A (only rsFC outcome measure were planned)</td><td rowspan="2" colspan="1">Weighted node degree</td></tr><tr><td rowspan="1" colspan="1">S:30</td></tr><tr><td rowspan="1" colspan="1">Schoellmann et al<sup><xref rid="bibr55-1179573520976832" ref-type="bibr">55</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Parkinsonâ€™s disease</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">Elderly</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Anodal</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">0.270</td><td rowspan="1" colspan="1">Nil</td><td rowspan="1" colspan="1">Not stated</td><td rowspan="1" colspan="1">Enhancement of specific neurological function (motor function)</td><td rowspan="1" colspan="1">Imaginary corticocortical coherence</td></tr><tr><td rowspan="1" colspan="1">Marangolo et al<sup><xref rid="bibr62-1179573520976832" ref-type="bibr">62</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Stroke-induced aphasia</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Bilateral</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">0.571</td><td rowspan="1" colspan="1">Syllable/word pronunciation training</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">Enhancement of specific neurological function (motor speech ability of trained items)</td><td rowspan="1" colspan="1">fMRI Eigenvector centrality</td></tr><tr><td rowspan="2" colspan="1">Ficek et al<sup><xref rid="bibr56-1179573520976832" ref-type="bibr">56</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1">Primary progressive aphasia</td><td rowspan="1" colspan="1">A:12</td><td rowspan="2" colspan="1">Elderly</td><td rowspan="2" colspan="1">No</td><td rowspan="2" colspan="1">Anodal</td><td rowspan="2" colspan="1">300</td><td rowspan="2" colspan="1">0.800</td><td rowspan="2" colspan="1">Oral/written naming task training</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Enhancement of specific neurological function (oral/written naming ability for trained and untrained items)</td><td rowspan="2" colspan="1">fMRI seed-seed rsFC</td></tr><tr><td rowspan="1" colspan="1">S:12</td></tr><tr><td rowspan="1" colspan="1">Lefebvre et al<sup><xref rid="bibr59-1179573520976832" ref-type="bibr">59</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Stroke</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">Elderly</td><td rowspan="1" colspan="1">Not stated</td><td rowspan="1" colspan="1">Bilateral</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">0.286</td><td rowspan="1" colspan="1">Motor skill learning</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Enhancement of specific neurological function (execution of learnt motor skill)</td><td rowspan="1" colspan="1">fMRI seed-whole brain rsFC</td></tr><tr><td rowspan="2" colspan="1">Nicolo et al<sup><xref rid="bibr60-1179573520976832" ref-type="bibr">60</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1"/><td rowspan="1" colspan="1">A:12</td><td rowspan="2" colspan="1">Elderly</td><td rowspan="2" colspan="1">Not stated</td><td rowspan="2" colspan="1">Bilateral</td><td rowspan="2" colspan="1">200</td><td rowspan="2" colspan="1">0.286</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Enhancement of specific neurological function (upper limb function)</td><td rowspan="2" colspan="1">Weighted node degree</td></tr><tr><td rowspan="1" colspan="1">S:12</td></tr><tr><td rowspan="1" colspan="1">Thibaut et al<sup><xref rid="bibr61-1179573520976832" ref-type="bibr">61</xref></sup></td><td rowspan="1" colspan="1">Crossover</td><td rowspan="1" colspan="1">Disorders of consciousness</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Bilateral</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Nil</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Enhancement of specific neurological function (spasticity)</td><td rowspan="1" colspan="1">EEG phase lagged index</td></tr><tr><td rowspan="2" colspan="1">Wu et al<sup><xref rid="bibr63-1179573520976832" ref-type="bibr">63</xref></sup></td><td rowspan="2" colspan="1">Parallel</td><td rowspan="2" colspan="1"/><td rowspan="1" colspan="1">A:5</td><td rowspan="2" colspan="1">Adult</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Anodal</td><td rowspan="2" colspan="1">200</td><td rowspan="2" colspan="1">0.571</td><td rowspan="2" colspan="1">Nil</td><td rowspan="2" colspan="1">N/A</td><td rowspan="2" colspan="1">Enhancement of global neurological function</td><td rowspan="2" colspan="1">Coherence</td></tr><tr><td rowspan="1" colspan="1">S:5</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-1179573520976832"><p>Abbreviations: A, active-tDCS; ADHD, attention-deficit/hyperactivity disorder; EEG, electroencephalography; fMRI, functional magnetic resonance imaging; N, number of participants; N/A, not applicable; rsFC, resting-state functional connectivity; S, sham-tDCS.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of the demographic, experimental, and outcome measurement details of the included studies.</div><div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th align="left" rowspan="2">Reference</th><th align="left" rowspan="2">Study design</th><th align="left" colspan="4">Participants characteristics</th><th align="left" colspan="5">Experimental details</th><th align="left" colspan="2">Outcome measures</th></tr><tr><th align="left">Neurological diagnosis</th><th align="left">N</th><th align="left">Age group</th><th align="left">Concurrent medication</th><th align="left">Stimulation type</th><th align="left">Total stimulation time (min)</th><th align="left">Current density (A/m2)</th><th align="left">Concurrent task</th><th align="left">Mean washout period (d)</th><th align="left">Clinical outcome (description)</th><th align="left">rsFC outcome</th></tr></thead><tbody><tr><td rowspan="2">De Ridder and Vanneste???</td><td rowspan="2">Parallel</td><td rowspan="2">Fibromyalgia</td><td>A:19</td><td rowspan="2">Adult</td><td rowspan="2">Yes</td><td rowspan="2">Bilateral</td><td rowspan="2">300</td><td rowspan="2">0.429</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">Symptomatic relief (pain perception)</td><td rowspan="2">EEG phase lagged index</td></tr><tr><td>S:12</td></tr><tr><td rowspan="2">Neeb et al???</td><td rowspan="2">Parallel</td><td rowspan="2">Inflammatory bowel disorder</td><td>A:24</td><td rowspan="2">Adult</td><td rowspan="2">Yes</td><td rowspan="2">Anodal</td><td rowspan="2">100</td><td rowspan="2">0.571</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td/><td rowspan="2">fMRI whole-brain rsFC</td></tr><tr><td>S:12</td><td/></tr><tr><td>Porcaro et al???</td><td>Crossover</td><td>Multiple sclerosis</td><td>13</td><td>Adult</td><td>No</td><td>Anodal</td><td>75</td><td>Varied</td><td>Nil</td><td>Not stated</td><td>Symptomatic relief (fatigue perception)</td><td>EEG mutual information</td></tr><tr><td rowspan="2">Mondino et al???</td><td rowspan="2">Parallel</td><td rowspan="2">Schizophrenia</td><td>A:11</td><td rowspan="2">Adult</td><td rowspan="2">Yes</td><td rowspan="2">Cathodal</td><td rowspan="2">200</td><td rowspan="2">0.571</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">Symptomatic relief (auditory hallucination)</td><td rowspan="4">fMRI seed-whole brain rsFC</td></tr><tr><td>S:12</td></tr><tr><td rowspan="2">Palm et al???</td><td rowspan="2">Parallel</td><td rowspan="2"/><td>A:10</td><td rowspan="2">Adult</td><td rowspan="2">Yes</td><td rowspan="2">Anodal</td><td rowspan="2">200</td><td rowspan="2">0.571</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">Symptomatic relief (psychiatric symptoms)</td></tr><tr><td>S:10</td></tr><tr><td>Shahbabaie et al???</td><td>Crossover</td><td>Substance abuse</td><td>15</td><td>Adult</td><td>No</td><td>Bilateral</td><td>20</td><td>0.571</td><td>Nil</td><td>7</td><td>Symptomatic relief (drug craving intention)</td><td>fMRI whole-brain rsFC</td></tr><tr><td>Sotnikova et al???</td><td>Crossover</td><td>ADHD</td><td>13</td><td>Adolescent</td><td>Yes</td><td>Anodal</td><td>20</td><td>0.769</td><td>n-back task</td><td>14</td><td>Enhancement of specific neurological function (working memory performance)</td><td>fMRI seed-whole brain rsFC</td></tr><tr><td rowspan="2">Cosmo et al???</td><td rowspan="2">Parallel</td><td rowspan="2"/><td>A:30</td><td rowspan="2">Adult</td><td rowspan="2">Not stated</td><td rowspan="2">Bilateral</td><td rowspan="2">20</td><td rowspan="2">0.286</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">N/A (only rsFC outcome measure were planned)</td><td rowspan="2">Weighted node degree</td></tr><tr><td>S:30</td></tr><tr><td>Schoellmann et al???</td><td>Crossover</td><td>Parkinsonâ€™s disease</td><td>10</td><td>Elderly</td><td>No</td><td>Anodal</td><td>20</td><td>0.270</td><td>Nil</td><td>Not stated</td><td>Enhancement of specific neurological function (motor function)</td><td>Imaginary corticocortical coherence</td></tr><tr><td>Marangolo et al???</td><td>Crossover</td><td>Stroke-induced aphasia</td><td>9</td><td>Adult</td><td>No</td><td>Bilateral</td><td>300</td><td>0.571</td><td>Syllable/word pronunciation training</td><td>14</td><td>Enhancement of specific neurological function (motor speech ability of trained items)</td><td>fMRI Eigenvector centrality</td></tr><tr><td rowspan="2">Ficek et al???</td><td rowspan="2">Parallel</td><td rowspan="2">Primary progressive aphasia</td><td>A:12</td><td rowspan="2">Elderly</td><td rowspan="2">No</td><td rowspan="2">Anodal</td><td rowspan="2">300</td><td rowspan="2">0.800</td><td rowspan="2">Oral/written naming task training</td><td rowspan="2">N/A</td><td rowspan="2">Enhancement of specific neurological function (oral/written naming ability for trained and untrained items)</td><td rowspan="2">fMRI seed-seed rsFC</td></tr><tr><td>S:12</td></tr><tr><td>Lefebvre et al???</td><td>Crossover</td><td>Stroke</td><td>22</td><td>Elderly</td><td>Not stated</td><td>Bilateral</td><td>30</td><td>0.286</td><td>Motor skill learning</td><td>N/A</td><td>Enhancement of specific neurological function (execution of learnt motor skill)</td><td>fMRI seed-whole brain rsFC</td></tr><tr><td rowspan="2">Nicolo et al???</td><td rowspan="2">Parallel</td><td rowspan="2"/><td>A:12</td><td rowspan="2">Elderly</td><td rowspan="2">Not stated</td><td rowspan="2">Bilateral</td><td rowspan="2">200</td><td rowspan="2">0.286</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">Enhancement of specific neurological function (upper limb function)</td><td rowspan="2">Weighted node degree</td></tr><tr><td>S:12</td></tr><tr><td>Thibaut et al???</td><td>Crossover</td><td>Disorders of consciousness</td><td>14</td><td>Adult</td><td>Yes</td><td>Bilateral</td><td>20</td><td>Unknown</td><td>Nil</td><td>2</td><td>Enhancement of specific neurological function (spasticity)</td><td>EEG phase lagged index</td></tr><tr><td rowspan="2">Wu et al???</td><td rowspan="2">Parallel</td><td rowspan="2"/><td>A:5</td><td rowspan="2">Adult</td><td rowspan="2">Yes</td><td rowspan="2">Anodal</td><td rowspan="2">200</td><td rowspan="2">0.571</td><td rowspan="2">Nil</td><td rowspan="2">N/A</td><td rowspan="2">Enhancement of global neurological function</td><td rowspan="2">Coherence</td></tr><tr><td>S:5</td></tr></tbody></table></div>Abbreviations: A, active-tDCS; ADHD, attention-deficit/hyperactivity disorder; EEG, electroencephalography; fMRI, functional magnetic resonance imaging; N, number of participants; N/A, not applicable; rsFC, resting-state functional connectivity; S, sham-tDCS.</transformed-table></extracted-table><extracted-table><table-id>table2-1179573520976832</table-id><table-label>Table 2.</table-label><table-caption>Summary of resting-state functional connectivity results from the functional magnetic resonance imaging (fMRI) studies.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="table2-1179573520976832" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Summary of resting-state functional connectivity results from the functional magnetic resonance imaging (fMRI) studies.</p></caption><alternatives><graphic xlink:href="10.1177_1179573520976832-table2"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="3" colspan="1">Reference</th><th align="left" rowspan="3" colspan="1">Significant changes in primary clinical outcome?</th><th align="left" rowspan="3" colspan="1">rsFC changes correlated with primary clinical outcome?</th><th align="left" colspan="2" rowspan="2">Montage placement</th><th align="left" colspan="14" rowspan="1">Brain regions reported significant rsFC differences (<italic>t</italic>-test FWE corrected <italic>P</italic>â€‰&lt;â€‰.05) between active and sham tDCS (classified in terms of resting-state network and direction of effect)</th></tr><tr><th align="left" colspan="2" rowspan="1">Visual</th><th align="left" colspan="2" rowspan="1">Somatomotor</th><th align="left" colspan="2" rowspan="1">Dorsal attention</th><th align="left" colspan="2" rowspan="1">Ventral attention</th><th align="left" colspan="2" rowspan="1">Limbic</th><th align="left" colspan="2" rowspan="1">Frontoparietal</th><th align="left" colspan="2" rowspan="1">Default</th></tr><tr><th align="left" rowspan="1" colspan="1">Anode</th><th align="left" rowspan="1" colspan="1">Cathode</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th><th align="left" rowspan="1" colspan="1">Aâ€‰&gt;â€‰S</th><th align="left" rowspan="1" colspan="1">Sâ€‰&gt;â€‰A</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Lefebvre et al<sup><xref rid="bibr59-1179573520976832" ref-type="bibr">59</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ipsi-lesional M1</td><td rowspan="1" colspan="1">Contra-lesional M1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R PMC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R ACC</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Marangolo et al<sup><xref rid="bibr62-1179573520976832" ref-type="bibr">62</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ipsi-lesional IFG</td><td rowspan="1" colspan="1">Contra-lesional IFG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R PMC cerebllm</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R SMA, L MFG, cerebllm</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L ACC, L Precuneus, R MPFC</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Ficek et al<sup><xref rid="bibr56-1179573520976832" ref-type="bibr">56</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">L IFG</td><td rowspan="1" colspan="1">R cheek</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L MFG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L MTG</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Mondino et al<sup><xref rid="bibr51-1179573520976832" ref-type="bibr">51</xref></sup></td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">L DLPFC</td><td rowspan="2" colspan="1">L Temporo-parietal junction</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R IFG, insula</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="2" colspan="1">L AG, precuneus</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Neeb et al<sup><xref rid="bibr50-1179573520976832" ref-type="bibr">50</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">L/R M1</td><td rowspan="1" colspan="1">L/R supra-orbital region</td><td rowspan="1" colspan="1">L/R FG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R post-CG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R insula</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R ACC, L/R PCC, L MTG</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Palm et al<sup><xref rid="bibr27-1179573520976832" ref-type="bibr">27</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1">R supra-orbital region</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L MTG</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sotnikova et al<sup><xref rid="bibr57-1179573520976832" ref-type="bibr">57</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1">Cz</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R MFG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R AG, ACC, L ITG</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Shahbabaie et al<sup><xref rid="bibr53-1179573520976832" ref-type="bibr">53</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">R DLPFC</td><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R insula, L IFG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L/R LG, R precuneus, L MTG, R PCC, L/R MPFC, L/R ACC, L/R OFC</td><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn2-1179573520976832"><p>Abbreviations: A, active tDCS; ACC, anterior cingulate cortex; AG, angular gyrus; cerebllm, cerebellum; Cz, labelling in the EEG 10 to 20 system; DLPFC, dorsolateral prefrontal cortex; FG, fusiform gyrus; FEW, family-wise error; IFG, inferior frontal gyrus; ITG, inferior temporal gyrus; L, left; M1, primary motor cortex; MFG, middle frontal gyrus; MPFC, medial prefrontal gyrus; MTG, middle temporal gyrus; n.r., not reported; PCC, posterior cingulate cortex; PMC, premotor cortex; post-CG, postcentral gyrus; R, right; rsFC, resting state functional connectivity; S, sham tDCS; SFG, superior frontal gyrus.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of resting-state functional connectivity results from the functional magnetic resonance imaging (fMRI) studies.</div><div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th align="left" rowspan="3">Reference</th><th align="left" rowspan="3">Significant changes in primary clinical outcome?</th><th align="left" rowspan="3">rsFC changes correlated with primary clinical outcome?</th><th align="left" colspan="2" rowspan="2">Montage placement</th><th align="left" colspan="14">Brain regions reported significant rsFC differences (t-test FWE corrected Pâ€‰&lt;â€‰.05) between active and sham tDCS (classified in terms of resting-state network and direction of effect)</th></tr><tr><th align="left" colspan="2">Visual</th><th align="left" colspan="2">Somatomotor</th><th align="left" colspan="2">Dorsal attention</th><th align="left" colspan="2">Ventral attention</th><th align="left" colspan="2">Limbic</th><th align="left" colspan="2">Frontoparietal</th><th align="left" colspan="2">Default</th></tr><tr><th align="left">Anode</th><th align="left">Cathode</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th><th align="left">Aâ€‰&gt;â€‰S</th><th align="left">Sâ€‰&gt;â€‰A</th></tr></thead><tbody><tr><td>Lefebvre et al???</td><td>Yes</td><td>Yes</td><td>Ipsi-lesional M1</td><td>Contra-lesional M1</td><td/><td/><td>L/R PMC</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td>L/R ACC</td><td/></tr><tr><td>Marangolo et al???</td><td>Yes</td><td>Yes</td><td>Ipsi-lesional IFG</td><td>Contra-lesional IFG</td><td/><td/><td>L/R PMC cerebllm</td><td/><td>R SMA, L MFG, cerebllm</td><td/><td/><td/><td/><td/><td/><td/><td>L ACC, L Precuneus, R MPFC</td><td/></tr><tr><td>Ficek et al???</td><td>Yes</td><td>Yes</td><td>L IFG</td><td>R cheek</td><td/><td/><td/><td/><td>L MFG</td><td/><td/><td/><td/><td/><td/><td/><td>L MTG</td><td/></tr><tr><td rowspan="2">Mondino et al???</td><td rowspan="2">Yes</td><td rowspan="2">Yes</td><td rowspan="2">L DLPFC</td><td rowspan="2">L Temporo-parietal junction</td><td/><td/><td/><td/><td/><td/><td/><td>R IFG, insula</td><td/><td/><td/><td/><td rowspan="2">L AG, precuneus</td><td/></tr><tr><td/><td/><td/><td/><td/><td/><td/><td>L DLPFC</td><td/><td/><td/><td/><td/></tr><tr><td>Neeb et al???</td><td>Yes</td><td>n.r.</td><td>L/R M1</td><td>L/R supra-orbital region</td><td>L/R FG</td><td/><td>L/R post-CG</td><td/><td/><td/><td>L/R insula</td><td/><td/><td/><td/><td/><td>R ACC, L/R PCC, L MTG</td><td/></tr><tr><td>Palm et al???</td><td>Yes</td><td>No</td><td>L DLPFC</td><td>R supra-orbital region</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/><td>L MTG</td><td/></tr><tr><td>Sotnikova et al???</td><td>Yes</td><td>n.r.</td><td>L DLPFC</td><td>Cz</td><td/><td/><td/><td/><td>L/R MFG</td><td/><td/><td/><td/><td/><td/><td/><td>R AG, ACC, L ITG</td><td/></tr><tr><td>Shahbabaie et al???</td><td>Yes</td><td>Yes</td><td>R DLPFC</td><td>L DLPFC</td><td/><td/><td/><td/><td/><td/><td>R insula, L IFG</td><td/><td/><td/><td/><td/><td>L/R LG, R precuneus, L MTG, R PCC, L/R MPFC, L/R ACC, L/R OFC</td><td/></tr></tbody></table></div>Abbreviations: A, active tDCS; ACC, anterior cingulate cortex; AG, angular gyrus; cerebllm, cerebellum; Cz, labelling in the EEG 10 to 20 system; DLPFC, dorsolateral prefrontal cortex; FG, fusiform gyrus; FEW, family-wise error; IFG, inferior frontal gyrus; ITG, inferior temporal gyrus; L, left; M1, primary motor cortex; MFG, middle frontal gyrus; MPFC, medial prefrontal gyrus; MTG, middle temporal gyrus; n.r., not reported; PCC, posterior cingulate cortex; PMC, premotor cortex; post-CG, postcentral gyrus; R, right; rsFC, resting state functional connectivity; S, sham tDCS; SFG, superior frontal gyrus.</transformed-table></extracted-table><extracted-table><table-id>table3-1179573520976832</table-id><table-label>Table 3.</table-label><table-caption>Summary of resting-state functional connectivity results from the electroencephalography (EEG) studies.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="table3-1179573520976832" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Summary of resting-state functional connectivity results from the electroencephalography (EEG) studies.</p></caption><alternatives><graphic xlink:href="10.1177_1179573520976832-table3"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Reference</th><th align="left" rowspan="2" colspan="1">Significant changes in primary clinical outcome?</th><th align="left" rowspan="2" colspan="1">rsFC changes correlated with primary clinical outcome?</th><th align="left" colspan="2" rowspan="1">Montage placement</th><th align="left" colspan="5" rowspan="1">Between-group contrast in rsFC</th></tr><tr><th align="left" rowspan="1" colspan="1">Anode</th><th align="left" rowspan="1" colspan="1">Cathode</th><th align="left" rowspan="1" colspan="1">Delta</th><th align="left" rowspan="1" colspan="1">Theta</th><th align="left" rowspan="1" colspan="1">Alpha</th><th align="left" rowspan="1" colspan="1">Beta</th><th align="left" rowspan="1" colspan="1">Gamma</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Nicolo et al<sup><xref rid="bibr60-1179573520976832" ref-type="bibr">60</xref></sup></td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Ipsilesional supraorbital region</td><td rowspan="1" colspan="1">Contralesional M1</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">Weighted node degree of M1: n.s.</td><td rowspan="1" colspan="1">Weighted node degree of M1: Aâ€‰&gt;â€‰S (<italic>t</italic><sub>24</sub>â€‰=â€‰2.78, <italic>P</italic>â€‰=â€‰.01)</td><td rowspan="1" colspan="1">n.r.</td></tr><tr><td rowspan="1" colspan="1">De Ridder and Vanneste<sup><xref rid="bibr49-1179573520976832" ref-type="bibr">49</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">L occipital lobe</td><td rowspan="1" colspan="1">R occipital lobe</td><td rowspan="1" colspan="1">n.s.</td><td rowspan="1" colspan="1">n.s.</td><td rowspan="1" colspan="1">n.s.</td><td rowspan="1" colspan="1">Aâ€‰&gt;â€‰S (<italic>t</italic>-value n.r.; <italic>P</italic>â€‰&lt;â€‰.05)</td><td rowspan="1" colspan="1">Aâ€‰&gt;â€‰S (<italic>t</italic>-value n.r.; <italic>P</italic>â€‰&lt;â€‰.05)</td></tr><tr><td rowspan="1" colspan="1">Cosmo et al<sup><xref rid="bibr58-1179573520976832" ref-type="bibr">58</xref></sup></td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1">R DLPFC</td><td colspan="5" rowspan="1">Whole-brain weighted node degree: n.s. (<italic>U</italic>â€‰=â€‰319.00; <italic>P</italic>â€‰=â€‰.92)</td></tr><tr><td rowspan="2" colspan="1">Porcaro et al<sup><xref rid="bibr54-1179573520976832" ref-type="bibr">54</xref></sup></td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">Primary sensory cortex</td><td rowspan="2" colspan="1">Occipital lobe</td><td colspan="5" rowspan="1">Treatment (pre,post)â€‰Ã—â€‰condition (real,sham): <italic>F</italic>(1,11)â€‰=â€‰13.235, <italic>P</italic>â€‰=â€‰.004</td></tr><tr><td colspan="5" rowspan="1">Post-hoc <italic>t</italic>-test: increase of FC between L and R M1 was significant (<italic>P</italic>â€‰=â€‰.0002), while remained non-significant for sham (<italic>P</italic>â€‰=â€‰.274)</td></tr><tr><td rowspan="1" colspan="1">Schoellmann et al<sup><xref rid="bibr55-1179573520976832" ref-type="bibr">55</xref></sup></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">L primary motor cortex</td><td rowspan="1" colspan="1">R supraorbital region</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">n.r.</td><td rowspan="1" colspan="1">n.s. (<italic>t</italic>-value n.r.; <italic>P</italic>â€‰&gt;â€‰.05)</td><td rowspan="1" colspan="1">n.r</td></tr><tr><td rowspan="2" colspan="1">Thibaut et al<sup><xref rid="bibr61-1179573520976832" ref-type="bibr">61</xref></sup></td><td rowspan="2" colspan="1">Yes</td><td rowspan="2" colspan="1">n.r.</td><td rowspan="2" colspan="1">Bilateral DLPFC</td><td rowspan="2" colspan="1">Bilateral M1</td><td rowspan="2" colspan="1">n.s.</td><td rowspan="2" colspan="1">n.s.</td><td rowspan="2" colspan="1">n.s.</td><td rowspan="1" colspan="1">Aâ€‰&gt;â€‰S; C3 to C4 (<italic>t</italic><sub>27</sub>â€‰=â€‰2.56, <italic>P</italic>â€‰=â€‰.02)</td><td rowspan="2" colspan="1">n.r.</td></tr><tr><td rowspan="1" colspan="1">Aâ€‰&gt;â€‰S; C4 to F3 (<italic>t</italic><sub>27</sub>â€‰=â€‰2.30, <italic>P</italic>â€‰=â€‰.04)</td></tr><tr><td rowspan="2" colspan="1">Wu et al<sup><xref rid="bibr63-1179573520976832" ref-type="bibr">63</xref></sup></td><td rowspan="2" colspan="1">No</td><td rowspan="2" colspan="1">n.r.</td><td rowspan="1" colspan="1">L DLPFC</td><td rowspan="1" colspan="1">R supraorbital region</td><td colspan="5" rowspan="1">Aâ€‰&gt;â€‰S (<italic>t</italic>-value n.r.; <italic>P</italic>â€‰&lt;â€‰.05)</td></tr><tr><td rowspan="1" colspan="1">R DLPFC</td><td rowspan="1" colspan="1">L supraorbital region</td><td colspan="5" rowspan="1">n.s.</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn3-1179573520976832"><p>Abbreviations: A, active-tDCS; DLPFC, dorsolateral prefrontal cortex; F3, labeling in the EEG 10 to 20 system; L, left; M1, primary motor cortex; n.r., not reported; n.s., non-significant; N/A, not applicable; R, right; rsFC, resting state functional connectivity; S, Sham-tDCS.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of resting-state functional connectivity results from the electroencephalography (EEG) studies.</div><div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th align="left" rowspan="2">Reference</th><th align="left" rowspan="2">Significant changes in primary clinical outcome?</th><th align="left" rowspan="2">rsFC changes correlated with primary clinical outcome?</th><th align="left" colspan="2">Montage placement</th><th align="left" colspan="5">Between-group contrast in rsFC</th></tr><tr><th align="left">Anode</th><th align="left">Cathode</th><th align="left">Delta</th><th align="left">Theta</th><th align="left">Alpha</th><th align="left">Beta</th><th align="left">Gamma</th></tr></thead><tbody><tr><td>Nicolo et al???</td><td>No</td><td>No</td><td>Ipsilesional supraorbital region</td><td>Contralesional M1</td><td>n.r.</td><td>n.r.</td><td>Weighted node degree of M1: n.s.</td><td>Weighted node degree of M1: Aâ€‰&gt;â€‰S (t24â€‰=â€‰2.78, Pâ€‰=â€‰.01)</td><td>n.r.</td></tr><tr><td>De Ridder and Vanneste???</td><td>Yes</td><td>Yes</td><td>L occipital lobe</td><td>R occipital lobe</td><td>n.s.</td><td>n.s.</td><td>n.s.</td><td>Aâ€‰&gt;â€‰S (t-value n.r.; Pâ€‰&lt;â€‰.05)</td><td>Aâ€‰&gt;â€‰S (t-value n.r.; Pâ€‰&lt;â€‰.05)</td></tr><tr><td>Cosmo et al???</td><td>N/A</td><td>N/A</td><td>L DLPFC</td><td>R DLPFC</td><td colspan="5">Whole-brain weighted node degree: n.s. (Uâ€‰=â€‰319.00; Pâ€‰=â€‰.92)</td></tr><tr><td rowspan="2">Porcaro et al???</td><td rowspan="2">Yes</td><td rowspan="2">Yes</td><td rowspan="2">Primary sensory cortex</td><td rowspan="2">Occipital lobe</td><td colspan="5">Treatment (pre,post)â€‰Ã—â€‰condition (real,sham): F(1,11)â€‰=â€‰13.235, Pâ€‰=â€‰.004</td></tr><tr><td colspan="5">Post-hoc t-test: increase of FC between L and R M1 was significant (Pâ€‰=â€‰.0002), while remained non-significant for sham (Pâ€‰=â€‰.274)</td></tr><tr><td>Schoellmann et al???</td><td>Yes</td><td>n.r.</td><td>L primary motor cortex</td><td>R supraorbital region</td><td>n.r.</td><td>n.r.</td><td>n.r.</td><td>n.s. (t-value n.r.; Pâ€‰&gt;â€‰.05)</td><td>n.r</td></tr><tr><td rowspan="2">Thibaut et al???</td><td rowspan="2">Yes</td><td rowspan="2">n.r.</td><td rowspan="2">Bilateral DLPFC</td><td rowspan="2">Bilateral M1</td><td rowspan="2">n.s.</td><td rowspan="2">n.s.</td><td rowspan="2">n.s.</td><td>Aâ€‰&gt;â€‰S; C3 to C4 (t27â€‰=â€‰2.56, Pâ€‰=â€‰.02)</td><td rowspan="2">n.r.</td></tr><tr><td>Aâ€‰&gt;â€‰S; C4 to F3 (t27â€‰=â€‰2.30, Pâ€‰=â€‰.04)</td></tr><tr><td rowspan="2">Wu et al???</td><td rowspan="2">No</td><td rowspan="2">n.r.</td><td>L DLPFC</td><td>R supraorbital region</td><td colspan="5">Aâ€‰&gt;â€‰S (t-value n.r.; Pâ€‰&lt;â€‰.05)</td></tr><tr><td>R DLPFC</td><td>L supraorbital region</td><td colspan="5">n.s.</td></tr></tbody></table></div>Abbreviations: A, active-tDCS; DLPFC, dorsolateral prefrontal cortex; F3, labeling in the EEG 10 to 20 system; L, left; M1, primary motor cortex; n.r., not reported; n.s., non-significant; N/A, not applicable; R, right; rsFC, resting state functional connectivity; S, Sham-tDCS.</transformed-table></extracted-table></extracted-tables-set>